Earnings summaries and quarterly performance for NASDAQ.
Executive leadership at NASDAQ.
Adena Friedman
Detailed
Chair and Chief Executive Officer
CEO
BP
Bradley Peterson
Detailed
Executive Vice President and Chief Information Officer/Chief Technology Officer
BS
Bryan Smith
Detailed
Executive Vice President and Chief People Officer
JS
Jeremy Skule
Detailed
Executive Vice President and Chief Strategy Officer; Executive Chair, Financial Crime Management Technology
JZ
John Zecca
Detailed
Executive Vice President and Chief Legal, Risk and Regulatory Officer
MD
Michelle Daly
Detailed
Senior Vice President and Controller and Principal Accounting Officer
NG
Nelson Griggs
Detailed
President
SY
Sarah Youngwood
Detailed
Executive Vice President and Chief Financial Officer
TC
Tal Cohen
Detailed
President
Board of directors at NASDAQ.
AZ
Alfred Zollar
Detailed
Director
CB
Charlene Begley
Detailed
Director
EK
Essa Kazim
Detailed
Director
HS
Holden Spaht
Detailed
Director
JY
Jeffery Yabuki
Detailed
Director
JT
Johan Torgeby
Detailed
Director
KK
Kathryn Koch
Detailed
Director
MA
Melissa Arnoldi
Detailed
Director
MS
Michael Splinter
Detailed
Lead Independent Director
TK
Thomas Kloet
Detailed
Director
TT
Toni Townes-Whitley
Detailed
Director
Research analysts who have asked questions during NASDAQ earnings calls.
Alexander Blostein
Goldman Sachs
6 questions for NDAQ
Also covers: AB, AMG, AMP +31 more
Ashish Sabadra
RBC Capital Markets
5 questions for NDAQ
Also covers: ADP, CBOE, CLVT +20 more
Benjamin Budish
Barclays PLC
5 questions for NDAQ
Also covers: AB, APO, ARES +24 more
Brian Bedell
Deutsche Bank
5 questions for NDAQ
Also covers: AMG, AMTD, APO +23 more
Michael Cyprys
Morgan Stanley
5 questions for NDAQ
Also covers: AAMI, AMP, AMTD +30 more
OL
Owen Lau
Oppenheimer & Co. Inc.
5 questions for NDAQ
Also covers: CLVT, CME, COIN +8 more
AK
Alex Kramm
UBS Group AG
4 questions for NDAQ
Also covers: BR, CBOE, CBRE +15 more
PM
Patrick Moley
Piper Sandler & Co.
4 questions for NDAQ
Also covers: BGC, CBOE, CME +17 more
Craig Siegenthaler
Bank of America
3 questions for NDAQ
Also covers: AB, AMP, AMTD +26 more
DF
Dan Fannon
Jefferies & Company Inc.
3 questions for NDAQ
Also covers: AB, AMG, AMTD +24 more
DF
Daniel Fannon
Jefferies Financial Group Inc.
3 questions for NDAQ
Also covers: AB, AMG, AMTD +27 more
JS
Jeff Schmitt
William Blair & Company, L.L.C.
3 questions for NDAQ
Also covers: AIZ, AMP, FRGE +8 more
Kyle Voigt
Keefe, Bruyette & Woods
3 questions for NDAQ
Also covers: AMTD, APO, ARES +17 more
MC
Michael Cho
JPMorgan Chase & Co.
3 questions for NDAQ
Also covers: ENV, FHI, FRGE +3 more
EA
Eli Abboud
Bank of America
2 questions for NDAQ
Also covers: BGC, CBOE, CME +2 more
SC
Simon Clinch
Redburn Atlantic
2 questions for NDAQ
Also covers: CME, EFX, FICO +4 more
WK
William Katz
TD Cowen
2 questions for NDAQ
Also covers: AB, AMG, AMTD +25 more
YC
Y. Cho
JPMorgan Chase & Co.
2 questions for NDAQ
Also covers: LPLA
AK
Alexander Kramm
UBS Group AG
1 question for NDAQ
Ben Budish
Barclays PLC
1 question for NDAQ
Also covers: AB, APO, ARES +20 more
Brian Bertram Bedell
Deutsche Bank AG
1 question for NDAQ
CA
Christopher Allen
Citigroup
1 question for NDAQ
Also covers: CBOE, CME, ETOR +9 more
JS
Jeffrey Schmitt
William Blair
1 question for NDAQ
Also covers: AIZ, AMP, CBOE +8 more
KS
Kwun Sum Lau
Oppenheimer
1 question for NDAQ
Also covers: CBOE, CLVT, CME +9 more
SA
Simon Alistair Clinch
Redburn Atlantic
1 question for NDAQ
Also covers: CME, EFX, FICO +3 more
Recent press releases and 8-K filings for NDAQ.
Baker Hughes announces Q4 and full-year 2025 results
NDAQ
Earnings
- Q4 orders were $7.9 billion, including $4.0 billion in Industrial & Energy Technology (IET), and record remaining performance obligations (RPO) of $35.9 billion (IET RPO $32.4 billion).
- Q4 revenue was $7.4 billion (flat YoY); net income attributable to Baker Hughes was $876 million; GAAP diluted EPS $0.88, adjusted diluted EPS $0.78; adjusted EBITDA $1,337 million (+2% YoY).
- Full-year 2025 orders reached $29.6 billion (including record $14.9 billion IET), revenue was $27.7 billion (flat YoY), net income was $2,588 million, and adjusted EBITDA was $4,825 million (+5% YoY).
- Q4 free cash flow was $1,341 million, and full-year free cash flow was $2,732 million.
43 minutes ago
Freight Technologies launches Zayren Pro with next-generation AI agents
NDAQ
Product Launch
Revenue Acceleration/Inflection
- Freight Technologies launched Zayren Pro, a premium commercial evolution of its AI-driven predictive pricing and matching platform designed to drive subscription-based SaaS revenue.
- The new tier offers agentic AI capabilities, unlimited query capacity and a proprietary carrier portal to scale its digital freight network across the U.S.–Mexico corridor.
- Zayren Pro extends the platform from rate prediction to direct procurement execution by autonomously shortlisting carriers and enabling direct bookings.
- CEO Javier Selgas said Zayren Pro monetizes rate prediction and captures cross-border nearshoring demand with a unified, scalable technology stack.
3 days ago
BioStem Technologies acquires BioTissue’s surgical and wound care business
NDAQ
M&A
- BioStem acquired the surgical and wound care business of BioTissue Holdings, including the Neox® and Clarix® product lines, nationwide direct sales force and GPO contracts.
- The deal involves an upfront cash payment of approximately $15 million, with up to $10 million in regulatory milestone and $15 million in commercial royalty payments; the acquired assets reported $29 million in sales in 2025 and are expected to deliver positive EBITDA in 2026, while BioStem’s post-closing cash balance is $16 million.
- Barry Hassett was promoted to Chief Commercial Officer to integrate and lead the expanded commercial organization across hospital inpatient and outpatient settings.
4 days ago
FG Nexus updates share buyback and ETH holdings
NDAQ
Share Buyback
- FG Nexus repurchased 9.9 million common shares at an average of $3.24 and 53 thousand preferred shares at $24.16 through January 20, 2026.
- As of January 20, 2026, the Company held 37,594 ETH and had $1.9 million in total debt outstanding.
- Outstanding shares totaled 33.6 million common and 0.8 million preferred, with a NAV of $3.58 per share.
4 days ago
Serve Robotics to acquire Diligent Robotics
NDAQ
M&A
- Serve Robotics to acquire Diligent Robotics, expanding its Physical AI platform into indoor healthcare with Diligent’s Moxi robot deployed in over 25 U.S. hospitals and completing 1.25 million deliveries.
- The acquisition values Diligent at $29.0 million in Serve common stock, with a potential additional $5.3 million earn-out upon milestone achievement.
- Serve will integrate Moxi into its shared autonomy stack, aiming to accelerate AI learning and scale operations across indoor and outdoor environments.
- The transaction is expected to close in Q1 2026, subject to customary closing conditions.
5 days ago
Nasdaq ETF PCMM reaches $185M AUM in first year
NDAQ
- PCMM has amassed $185 million in assets under management, offering a 7.22% yield-to-maturity and 6.49% SEC yield as of January 14, 2026.
- The ETF exhibited one-eighteenth the volatility of the S&P 500 and one-quarter the volatility of the Bloomberg U.S. Aggregate Bond Index in 2025, underscoring its stabilizing role in portfolios.
- BondBloxx executives rang the Nasdaq closing bell to commemorate PCMM’s one-year anniversary, highlighting its daily liquidity, transparency, and 50% lower management fee versus typical interval funds.
- PCMM and BondBloxx garnered industry recognition in late 2025, including Best Fixed Income Asset Manager at the WealthManagement.com “Wealthies” Awards, plus honors from ETF Express and MMI/Barron’s.
5 days ago
Boundless Bio advances novel Kinesin degrader program and extends cash runway
NDAQ
Product Launch
Guidance Update
- Boundless Bio’s IND application for BBI-940, a first-in-class oral Kinesin degrader targeting metastatic breast cancer, has been accepted by the FDA, enabling initiation of the KOMODO-1 first-in-human trial in 1H 2026.
- The company has ceased enrollment in its Phase 1/2 POTENTIATE trial of BBI-355 and BBI-825 to sharpen focus on its highest-priority ecDNA-directed therapeutic candidate.
- Under a revised operating plan, Boundless Bio’s cash runway now extends into the second half of 2028, covering the anticipated initial proof-of-concept readout for BBI-940.
5 days ago
Hotel101 Global signs agreements for 766-room Melbourne development
NDAQ
New Projects/Investments
- Hotel101 Global (NASDAQ: HBNB) signed definitive binding agreements to develop a 766-room Hotel101 in Melbourne’s CBD at 540 Flinders Lane, set to be the city’s largest hotel by room count.
- The project, pending regulatory approvals, is expected to generate approx. AU$323.6 million in sales revenue upon full sale and reach completion by 2029.
- This development supports Hotel101’s prop-tech “condotel” expansion strategy, targeting medium-term presence in 25 countries and a long-term goal of 1 million rooms across 100 countries.
- As of January 16, 2026, Hotel101 Global held a market capitalization of approx. US$2.34 billion, with its first operational project, Hotel101-Madrid, opening by March 2026.
6 days ago
AlphaTON Capital signs agreement to launch privacy-preserving AI agents on Telegram
NDAQ
Product Launch
New Projects/Investments
- Strategic partnership: AlphaTON Capital and the Midnight Foundation will integrate a zero-knowledge blockchain with the TON ecosystem to deliver fully privacy-preserving AI agents to Telegram’s nearly 1 billion users.
- Signed Federated Node Agreement: Effective December 30, 2025, the agreement secures day-one revenue with monthly compensation for Proof of Concept development and node services starting Q1 2026, plus reimbursement for network growth costs.
- First-to-market integration: Combines Telegram’s Cocoon AI confidential compute infrastructure with Midnight’s programmable privacy layer, ensuring user data ownership and confidentiality across AI applications.
- Scalable revenue model: Positions AlphaTON to capture a first-mover advantage in a market projected to reach trillions of dollars, solidifying its leadership in decentralized AI infrastructure.
6 days ago
Faraday Future to Launch EAI Robotics and FX Par Model at NADA Show
NDAQ
Product Launch
New Projects/Investments
- Faraday Future will hold the final launch of its EAI robotics products and host the FF/FX Par Partner Recruitment Conference on February 4 at the NADA Show in Las Vegas, marking the first introduction of embodied AI robotics to the automotive dealer community.
- The FX Par co-creation ecosystem upgrades the traditional dealer model into a sustainable system that generates continuous value through vehicle sales, user operations and equity participation for dealers.
- FF will exhibit the FF 91, FX Super One and EAI robotics solutions at the UMEX 2026 aviation show in Abu Dhabi from January 20–22 to showcase its EAI innovations to global partners.
- Production optimization for the FX Super One is underway at the Hanford factory following the first pre-production vehicle off the line, preparing for delivery and ramp-up.
6 days ago
Fintool News
In-depth analysis and coverage of NASDAQ.
Quarterly earnings call transcripts for NASDAQ.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more